Currently out of the existing stock ratings of Andrea Tan, 23 are a BUY (62.16%), 11 are a HOLD (29.73%), 3 are a SELL (8.11%).

Andrea Tan

Work Performance Price Targets & Ratings Chart

Analyst Andrea Tan, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 34.85% that have a potential upside of 34.16% achieved within 197 days.

Andrea Tan’s has documented 73 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 02-Oct-2025.

Wall Street Analyst Andrea Tan

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/15/2024. The price target of $49 was fulfilled within 14 days with a profit of $24.07 (96.55%) receiving and performance score of 68.96.

Average potential price target upside

of $28.81 (122.94%) on INSM (INSMED).
of $6.03 (15.03%) on TARS (TARSUS PHARMACEUTICALS ).
of $2.84 (89.87%) on SGMT (SAGIMET BIOSCIENCES SERIES A COMMON STOCK).

CDAK Codiak BioSciences DAWN Day One Biopharmaceuticals FATE Fate Therapeutics INSM Insmed MDGL Madrigal Pharmaceuticals RLMD Relmada Therapeutics ABCL Abcellera Biologics CNTA Centessa Pharmaceuticals PLC ADR IOVA Iovance Biotherapeutics TARS Tarsus Pharmaceuticals SGMT Sagimet Biosciences Series A Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Andrea Tan (GOLDMAN SACHS)